Tenofovir Alafenamide Switch Therapy in Chronic Hepatitis B
Condition(s):Patient Satisfaction; Drug Adherence; Efficacy, Self; Safety IssuesLast Updated:November 7, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Patient Satisfaction; Drug Adherence; Efficacy, Self; Safety IssuesLast Updated:November 7, 2023Recruiting
Condition(s):HealthyLast Updated:July 27, 2022Completed
Condition(s):HealthyLast Updated:July 7, 2020Terminated
Condition(s):HIV I Infection; Cardiovascular Risk Factor; Lipid Metabolism DisordersLast Updated:March 12, 2024Recruiting
Condition(s):Antiviral DrugsLast Updated:July 12, 2022Completed
Condition(s):Chronic Hepatitis bLast Updated:December 22, 2020Recruiting
Condition(s):Chronic Hepatitis bLast Updated:November 29, 2023Recruiting
Condition(s):Chronic Hepatitis b; Cirrhosis Due to Hepatitis BLast Updated:October 29, 2020Recruiting
Condition(s):Chronic Hepatitis b; Hepatitis B ReactivationLast Updated:August 5, 2021Unknown status
Condition(s):Renal Insufficiency,Chronic; Hiv; Therapeutic Agent ToxicityLast Updated:January 28, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.